We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Diabetes Inpatient Audit - Harms, 2019Audit
- Publication Date:
- 13 Nov 2020
- Geographic Coverage:
- Geographical Granularity:
- NHS Trusts, Hospital Sites
NaDIA-Harms is a mandatory year-round collection of four harms that can occur to diabetic inpatients in Acute hospitals in England.
The Audit seeks to monitor these four complications:
Did the patient require injectable rescue treatment for Hypoglycaemia (Hypo) more than 6 hours after admission?
Was the patient diagnosed with new onset Diabetic KetoAcidosis (DKA) more than 24 hours after admission?
Was the patient diagnosed with new onset Hyperglycaemic Hyperosmolar State (HHS) more than 24 hours after admission?
Was the patient diagnosed with a new onset foot ulcer more than 72 hours after admissions?
The 2019 snapshot NaDIA annual report can be found here: http://digital.nhs.uk/pubs/nadia2019
Recommendation 1: Acute hospitals should all participate in NaDIA-Harms, an important improvement initiative.
Recommendation 2: Healthcare professionals should be aware of the increased risk of harm in hospital inpatients with higher risk characteristics.
100, out of a possible 131, NHS trusts submit data to the audit.
High risk characteristics have been determined by linking to characteristics held in the core National Diabetes Audit (NDA)